Skip to search formSkip to main contentSkip to account menu

BIIB022

Known as: Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022, BIIB-022 
A recombinant, human monoclonal antibody directed against the insulin-like growth factor 1 receptor (IGF-1R) with potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
SummaryPurpose The IGF-1R signaling pathway has been implicated in multiple cancers as important for cell survival, proliferation… 
2010
2010
2612 Background: The IGF pathway is believed to play a key role in the pathogenesis of several tumors. BIIB022 is a human… 
Review
2009
Review
2009
The insulin-like growth factor 1 receptor (IGF-1R) and its associated signalling system has provoked considerable interest over… 
2009
2009
Biogen Idec has expanded its agreement to discover additional antibody products using Dyax’s phage display drug discovery… 
2008
2008
4002 Antibodies to IGF-1R as inhibitors of PI3K/AKT survival pathway have shown evidence of objective responses in early clinical… 
2007
2007
B210 Antibodies targeting human type I insulin-like growth factor receptor (IGF-1R) as inhibitors of tumor survival pathway have…